FdaApplication

ANDA 217598

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeANDA
approval_date2024-11-18

Products (1)

ProductActive ingredientStrengthDosage form
LORAZEPAMLORAZEPAM2MG/MLINJECTABLE;INJECTION

1 product